chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a 78 year old male on 03-MAY-2007 was vaccinated with a dose of Zostavax. On approximately 03-MAY-2007, the patient experienced throat infection and difficulty swallowing. No further information is available.
Pt developed a temperature of 103F within 24 hours, post vax. No other symptoms developed. Resolved within 24 hours.
Approx. 15 mins into observation time of 30 mins. client reported redness of hands. Client moved to private room , BP taken twice. 186/112 and 186/106, Benadryl administered. EMS called. Client began reporting itching of arms and legs. Then tingling of tongue. No swelling or airway obstruction noted. Client sent to hospital via EMS.  Client was AAO x3 upon leaving clinic.
Rash on face around mouth and eyes after the 1st shot on June 7th.  Rash on both hands and arms and feet. After July 7tg
My arm remained sore for the week after the injection. After week one the pain continued to get worse. At 3 weeks post injection I developed severe pain in arm and was unable to raise the arm. I then saw my primary care Dr who prescribed tranadol 1-2 tablets 4x daily. One pill did nothing so the 2 pill dose has helped while taking it I have less pain and can again move my arm.
achiness; slight headache; nausea; This is a spontaneous report from a contactable consumer (patient). A 73-year-old non-pregnant female patient received first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number: EL9263), via an unspecified route of administration, administered in arm right on 27Jan2021 10:15 (at the age of 73-years-old) as dose 1, single for covid-19 immunization. Medical history included chronic obstructive pulmonary disease (copd), high blood pressure (high bp), high cholesterol, essential tremor, gastroesophageal reflux disease (gerd), arthritis. The patient previously took Macrobid [nitrofurantoin] and experienced drug hypersensitivity (Allergies to medications, food, or other products: macrobid). Concomitant medication included propranolol (MANUFACTURER UNKNOWN), via an unspecified route of administration on an unspecified date at unknown dose and frequency for unknown indication; atorvastatin (MANUFACTURER UNKNOWN), via an unspecified route of administration on an unspecified date at unknown dose and frequency for unknown indication; pantoprazole (MANUFACTURER UNKNOWN), via an unspecified route of administration on an unspecified date at unknown dose and frequency for unknown indication; Olmesartan (MANUFACTURER UNKNOWN), via an unspecified route of administration on an unspecified date at unknown dose and frequency for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Jan2021 13:30, the patient experienced achiness, slight headache, nausea. The patient did not receive any treatment for the adverse event. The reported seriousness of the events was non-serious. The clinical outcome of the events was recovered in 2021.  Follow-up attempts are completed. No further information is expected.
2x3 1/2 in of redness, induration (1st discovered thursday);
Incorrect administration and dose of Td vaccine; 0.1mL given intradermally instead of PPD for Tb testing.  Patient experienced a reaction of a reddened area of at least 5mm with red streak extending to the elbow, numbness in the thumb and wrist.
Pt stated that she experienced lymph node swelling in her left armpit a few days after she was given the shingrix vaccine (she received the flu vaccine on her right deltoid on the same day). She stated that her lymph node swelling is gone and the bruising she developed later is significantly better so is the lymph node pain. Pt denies pain, numbness, tingling in her left arm/fingers and anywhere else in her body. Pt declined to come back in the clinic because she states she is feeling better and will return after February 2020 for her second Shingles shot.
Enlarged supraclavicular lymph node; Headache; Sore throat; Pain at injection site; Joint pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 17Sep2021 16:00 (Lot number: FF2589) at the age of 31 years as dose  2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Pfizer (Dose Number: 1, Batch/Lot No: FC3182, Location of injection: Arm Left, Vaccine Administration Time: 04:45 PM), administration date: 22Aug2021, for COVID-19 immunisation. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 02Oct2021, outcome "not recovered", described as "Enlarged supraclavicular lymph node"; HEADACHE (non-serious) with onset 02Oct2021, outcome "not recovered", described as "Headache"; OROPHARYNGEAL PAIN (non-serious) with onset 02Oct2021, outcome "not recovered", described as "Sore throat"; VACCINATION SITE PAIN (non-serious) with onset 02Oct2021, outcome "not recovered", described as "Pain at injection site"; ARTHRALGIA (non-serious) with onset 02Oct2021, outcome "not recovered", described as "Joint pain". The events "enlarged supraclavicular lymph node", "headache", "sore throat", "pain at injection site" and "joint pain" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of lymphadenopathy, headache, oropharyngeal pain, vaccination site pain, arthralgia.  Additional information- patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  No follow-up attempts are possible. No further information is expected.
Dose 1 Palpitations, increased heart rate. Shortness of breath. Heart rate in the hundreds even on meds. Struggle to work everyday. Dose-2 01/27/2021, at 9 PM my heart rate raised, vomiting, off work for 4 days. Lethargy, loss of appetite. End of Feb, contacted PCP, I was exhausted and fatigued and struggled with any activities. Thyroid test Graves disease diagnosed. I never had issues with thyroid, no family history of thyroid problems. My levels were extremely elevated. The only treatment was surgery to remove thyroid. Third week from thyroid surgery, went back to work on 4th week, I now have to be on thyroid medication for the rest of life. Hair was thinning and nails were brittle, still going on. Discontinued all medication except for new medication of Synthroid.
Mildly sore throat; Had a very swollen axillary (armpit) lymph node on right side (same side as the injection); This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the right arm on 06May2021 at 12:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure/cholesterol, which were treated with unspecified medications and allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included valsartan (MANUFACTURER UNKNOWN) and pravastatin (MANUFACTURER UNKNOWN); both for unknown indications from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the right arm on 15Apr2021 at 23:45 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. On 07May2021 at 06:00, the next morning after vaccination, the patient had a very swollen axillary (armpit) lymph node on right side (same side as the injection). The node felt like a bag of fluid was under the surface. On 10May2021, the 4th morning after vaccination, it was still present but seemed to be getting smaller the last 2 days and the patient had a mildly sore throat. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events had a very swollen axillary (armpit) lymph node on right side (same side as the injection) and mildly sore throat was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
tiredness headache fever body aches all over extremely ache to any movement  nose burns on the inside
Rash on injection site. Flu-like symptoms (fever, myalgia) which ended after 48 hours.
Patient called saying she was experiencing tingling in her left arm. She said it started from her ring finger and was going up her arm.
Pt received Twinrix vaccine on 1/30/08. About 3 days after receiving vaccine he developed bumps on his neck bilaterally which were somewhat itchy. Bumps were somewhat "hive like" on (L) side of neck but less prominent on (R) side.
This case was reported by a nurse and described the occurrence of stomach pain in a 6 year old female patient who received hepatitis A vaccine inactivated (Havrix).  The patient's medical history included reactive airway disease, and allergy to nuts, animals, pollen, shellfish, and dustmites.  At the time of administration of the second dose of Havrix, the patient was not receiving any concurrent medications.  On 07/21/2004, the patient received the second dose of Havrix (lot VHA839A2).  On the same day as the administration of Havrix, on 07/21/2004, the patient experienced stomach pain and had one loose bowel movement.  The loose bowel movement resolved on 07/21/2004 and the stomach pain resolved on 07/23/2004.  The nurse considered the events to not be related to vaccination with Havrix.
Initial unsolicited case received from other non-health care professional on 13 Mar 2017. This case involves a 50 year old female patient who was vaccinated with dose one of FLUZONE ID (Batch number: UT5569BA, expiry date: 30 Jun 2017, dose , route and site of administration was unknown) on 05 Dec 2016. The patient had no illness at the time of vaccination, the patient had BACTRIM and Lisinopril allergies, any other vaccinations within 4 weeks of vaccinations was reported as none. Concomitant medications were not reported. On 06 Dec 2016, one day after the vaccination in the morning the patient experienced a softball size red raised area with heat and pain, the patient required ER/doctor visit and it was reported as on 07 Mar 2017, when the patient returned to office she still has a red area on her arm about the size of a dime. It's not raised red or itchy as this point. The patient lab tests were reported as none. Corrective treatment was not reported. The outcome of the events were reported as not recovered. List of documents held by sender: none.
Information has been received from a pharmacist via a company representative referring to a female patient of unknown age. The patient's medical history, concurrent condition and concomitant therapy were unknown. On an unknown date, the patient was administered ZOSTAVAX 19400 PFU (lot#, expiration date, dose and route were not reported). On an unknown date, the patient had a nickel sized skin reaction at the injection site. The pharmacist did not recommend any treatment, but the patient applied NEOSPORIN on her own. The outcome of injection site reaction was unknown. The causality assessment between the event and ZOSTAVAX was not reported. Additional information has been requested.
patient states that she started experiencing a little nauseous and some stiffness in her back on 04/23/21, patient was given vaccine on 04/21/21
5/29 Approx 1900 began to have a welt about size of .25 piece. Painful at site, throbbing pain-no itching, hot to touch, raised, red. Throughout evening became bigger-approx 2"x 2" with hand center. Right arm 4/20 sam symptoms as above-very painful 4-5 period. Left arm on 5/31 (L) arm still has knot and is painful to touch. Thought it was a spider bite
The first week the injection site was red, swollen, itchy. and warm. Assumed the symptoms were normal, a week after the vaccine the area was still red, swollen warm, and itchy. Called pharmacy on May the 5th, the  I received vaccine at and was told to treat with ice, Ibuprofen, and Benadryl, may have been a injection site reaction. That following Friday the original area had calmed down but had developed a new spot underneath where I had the vaccine and then noticed another on Sunday the 9th. Have been icing area and taking Benadryl but  the area flares up in the morning.
Received dose #2 at 6:00 pm on 3/3/21. Arm soreness began within 2 hours, increasing throughout the night; pain radiated to fingertips; iced it at 3:00 am with success. Sleep was restless, waking often, with onset of flu-like aches throughout entire body. No fever. Mid-morning headache began to increase with nausea. Difficult to keep eyes open (tiredness), eat or drink. As day progressed, so did the headache and nausea. Taken to Emergency Room at 8:00 pm. Administered Zofran IV for nausea and IV NSAID. Nausea ceased; headache dulled. Released 11:00 pm. Only headache remained through Saturday, 3/6/21.
Patient after receiving vaccine said she wasn't feeling well and needed some water. She was nausea and sweating. She at one point appeared to pass out be she slumped in chair and her eyes fixated on the wall and she couldn't talk. This didn't last for long. We gave her some water and she at a granola bar which made her feel better. She had her boyfriend out in the store so we had him come and get her and after about 20 minutes she was able to leave with him. She said she was ok and wanted to go home. We told her to let us know if she needed anything and she was going to tell her doctor and I said I would also let the doctor know about the incident.
Pneumonia; This is a spontaneous report from a non-contactable consumer (patient) from a Pfizer sponsored program. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date  as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received 1st dose of vaccine and now she has pneumonia. She was told by her doctor to wait to receive her 2nd dose she was calling to cancel 2nd appointment in till she finishes her antibiotic. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Started dry cough for three day, pain across the lower back began two days after cough. Began intense pain with nausea and cold and clammy sweats. Called the nurse on my insurance who advised to get to the ER.
Gave 3rd dose (immunocompromised dose) of Pfizer instead of continuing with the Moderna series
Chills, body aches, fatigue. Took ibuprofen  started 12 hours after shot. Lasted 24 hours
no adverse event; multiple patients were vaccinated with an improperly stored vaccine; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported.  On 17-MAY-2019, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ), 2 ml, orally, lot # R034700, expiry date 16-JUN-2020 for prophylaxis. The vaccine was exposed to a temperature of 34.2 Fahrenheit degrees for 4 hours and 54 minutes. Digital data logger was involved. There were no previous temperature excursions. No adverse effects were reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1907USA000862: US-009507513-1906USA011674: US-009507513-1907USA000883: US-009507513-1907USA000884: US-009507513-1907USA000885: US-009507513-1907USA000926: US-009507513-1907USA000927: US-009507513-1907USA000886: US-009507513-1907USA000887: US-009507513-1907USA000888: US-009507513-1907USA000928: US-009507513-1907USA000930: US-009507513-1907USA000931: US-009507513-1907USA000932: US-009507513-1907USA000889: US-009507513-1907USA000890: US-009507513-1907USA000891: US-009507513-1907USA000892: US-009507513-1907USA000933: US-009507513-1907USA000934: US-009507513-1907USA000935: US-009507513-1907USA000893: US-009507513-1907USA000894: US-009507513-1907USA000895: US-009507513-1907USA000929: US-009507513-1907USA000936: US-009507513-1907USA000937: US-009507513-1907USA000938: US-009507513-1907USA000896: US-009507513-1907USA000897: US-009507513-1907USA000898: US-009507513-1907USA000899: US-009507513-1907USA000900: US-009507513-1907USA000901: US-009507513-1907USA000902: US-009507513-1907USA000904: US-009507513-1907USA000905: US-009507513-1907USA000906: US-009507513-1907USA000907: US-009507513-1907USA000908: US-009507513-1907USA000909: US-009507513-1907USA000910: US-009507513-1907USA000911: US-009507513-1907USA000912: US-009507513-1907USA000913: US-009507513-1907USA000914: US-009507513-1907USA000915: US-009507513-1907USA000916: US-009507513-1907USA000917: US-009507513-1907USA000918: US-009507513-1907USA000919: US-009507513-1907USA000920: US-009507513-1907USA000921: US-009507513-1907USA000922: US-009507513-1907USA000882: US-009507513-1907USA000923: US-009507513-1907USA000924: US-009507513-1907USA000925:
Information has been received from a nurse practitioner concerning a 16 year old female with asthma and no allergies who was vaccinated with the the third dose of GARDASIL (lot # 659182/1757U) on 23-DEC-2008. Concomitant therapy included ALBUTEROL and fluticasone propionate (+) ADVAIR. After the patient received GARDASIL and 5 minutes later she fainted. The patient recovered from faint on 23-DEC-2008. The patient was seen in the office for medical attention. Attempts to obtain more information had been failed. No further information was available.
Information has been received from a physician via company employees and a practice manager referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not provided. On 25-MAR-2015 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 0.5ml Prefilled Syringe (PFS) (lot # K020795, expiration date 19-MAR-2016, dose and route were unspecified). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time was 16 hours with the lowest recorded temperature of 33 Fahrenheit degree. The storage criteria and the type of excursion for this was 16 hours with the lowest recorded temperature of 33 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Hospitalized  hospitalized 10/1 t0o 10/5 covid pneumonia  Hospitalized again for encephalopathy increased confusion and combativeness in patient with neurocognitive disorder.
pt recv vax 11AM & had been medicated w/APAP @ approx 1030AM that day;w/in 1hr of vax pt began inconsolable crying;temp was 101 R w/med & RLT @ site was red-raised silver dollar size;spoke w/MD who advised if temp reached 102 bring pt to in
This case was reported by a other health professional via call center representative and described the occurrence of muscle soreness in a 63-year-old female patient who received SHINGRIX (batch number 4Y5KD, expiry date 10th April 2021) for prophylaxis. On 21st November 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On an unknown date, less than a month after receiving SHINGRIX, the patient experienced muscle soreness, pain in joint involving shoulder region, joint range of motion decreased and pain in arm. On an unknown date, the outcome of the muscle soreness, pain in joint involving shoulder region, joint range of motion decreased and pain in arm were not recovered/not resolved. It was unknown if the reporter considered the muscle soreness, pain in joint involving shoulder region, joint range of motion decreased and pain in arm to be related to SHINGRIX. Additional details were provided as follows: The caller was a medical assistant reporting an adverse event on behalf of the patient. The patient received SHINGRIX in the left deltoid. The reported stated that the patient received the dose of SHINGRIX. The patient developed soreness in her left arm that turned into left shoulder joint soreness and decrease in range of motion in the left shoulder.
Ischemic stroke,  air amublance, tomography, MRI, CT scans (mutiple), heart rythmn tracing,  outcome - long term memory loss and vocabulary difficulties, cognitive loss,
"Big bright red and slightly swollen arm"  She stated the redness was "Red as a Dodgeball" onset 05.05.21 thru 05.08.21. .  She also report generalized malaise "Tired & no Energy" during the same time frame.   She did not call her allergist or PCP as advised date of injection if she were to have a reaction/side effects.
Hyper, non stop cursing and talking, agitation, agression, violent, headaches, unable to sleep, not eating.  Symptoms lasted 23-25 days.
About 5 min after receiving a tetanus injection, donor slipped from chair to the floor.  Was moving arms, donor recovered in about 2 minutes.
Patient reported vomiting, fever, fatigue, coughing, congestion, shortness of breath and pain at injection site.
A 77 year old, female patient received PREVNAR 13 on 23Oct2013 at single dose to prevent pneumonia. Relevant medical history and concomitant medication was unknown. It was reported that the patient developed bad rashes all over the body since an unknown date in Oct2013. Relevant laboratory data was unknown. Therapeutic measures taken in response to the event included BENADRYL since an unknown date in Oct2013 (dose and frequency unknown). The patient had not recovered and the event was getting worse at the time of report. Follow-up (04Dec02013): Follow-up attempts completed. No further information expected.
My child (born completely healthy) suffers from severe and unbearable itching/chronic inflammation (with redness and discoloration under the skin's surface) - likely referred to as eczema (doctor indicated it is likely eczema and recommended topical treatments which have not provided relief because it does not treat the cause). This severe and unbearable itching around the clock with flair ups occurring particularly during the evening hours intereferes with normal function, sleep and quality of life. These symptoms were reported as early as the two week visit (and also noticed in pictures). At six months old now, she has suffered since then. I believe this is an adverse reaction to ingredients in the vaccine (i.e. aluminum, etc.) and the manifestation of a disruption in her extremely immature immune system. Either way, I regret having allowed this as my child, who was born perfectly healthy, suffers tremendously as a result.
Fatigue, moderate/severe body and muscle aches. Loss of appetite. Elevated heart rate, slight nausea
Bodyaches, headache developed 24 hours after vaccination.  Left hip pain and difficulty bearing weight began the following day, 19/30/09.